NEKTAR THERAPEUTICS (NKTR) Earnings History & Surprises
NASDAQ:NKTR • US6402683063
68.11 USD
-0.25 (-0.37%)
At close: Mar 3, 2026
68.7 USD
+0.59 (+0.87%)
After Hours: 3/3/2026, 8:00:02 PM
Past quarterly earnings results for NEKTAR THERAPEUTICS (NKTR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 4, 2026
PeriodQ4 / 2025
EPS Estimate-$2.52
Revenue Estimate10.612M
Last Reported
Release DateNov 6, 2025
PeriodQ3 / 2025
EPS Reported-$1.87
EPS Surprise 31.71%
Revenue Surprise 15.04%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -1.87 | -2.74 | 31.71% | 30.74% | 11.79M | 10.249M | 15.04% | -51.13% |
| Q2 2025 | -2.95 | -3.10 | 4.71% | 21.33% | 11.175M | 11.066M | 0.98% | -52.42% |
| Q1 2025 | -3.60 | -2.51 | -43.22% | -26.32% | 10.446M | 15.664M | -33.31% | -51.73% |
| Q4 2024 | -2.40 | -2.57 | 6.77% | 27.27% | 29.175M | 30.457M | -4.21% | 22.15% |
| Q3 2024 | -2.70 | -3.23 | 16.31% | 25.00% | 24.124M | 18.646M | 29.38% | -0.08% |
| Q2 2024 | -3.75 | -3.12 | -20.38% | 7.41% | 23.489M | 17.896M | 31.25% | 14.59% |
| Q1 2024 | -2.85 | -2.91 | 1.96% | 40.62% | 21.639M | 15.649M | 38.28% | 0.21% |
| Q4 2023 | -3.30 | -3.25 | -1.55% | 31.25% | 23.885M | 18.416M | 29.70% | 8.57% |
| Q3 2023 | -3.60 | -3.05 | -17.98% | 22.58% | 24.144M | 21.739M | 11.06% | 2.31% |
| Q2 2023 | -4.05 | -4.34 | 6.75% | 68.24% | 20.499M | 22.263M | -7.92% | -5.10% |
| Q1 2023 | -4.80 | -3.86 | -24.21% | 34.69% | 21.594M | 20.235M | 6.72% | -12.93% |
| Q4 2022 | -4.80 | -6.92 | 30.65% | 59.49% | 22M | 22.576M | -2.55% | -12.00% |
| Q3 2022 | -4.65 | -6.88 | 32.39% | 55.71% | 23.6M | 23.061M | 2.34% | -5.22% |
| Q2 2022 | -12.75 | -14.32 | 10.99% | -23.19% | 21.6M | 23.118M | -6.57% | -23.67% |
| Q1 2022 | -7.35 | -10.36 | 29.07% | 26.87% | 24.8M | 24.865M | -0.26% | 5.08% |
| Q4 2021 | -11.85 | -12.38 | 4.31% | -21.54% | 25M | 25.84M | -3.25% | 6.38% |
| Q3 2021 | -10.50 | -12.21 | 14.04% | -14.75% | 24.9M | 28.425M | -12.40% | -17.00% |
| Q2 2021 | -10.35 | -11.18 | 7.44% | -53.33% | 28.3M | 26.5M | 6.79% | -42.01% |
| Q1 2021 | -10.05 | -11.05 | 9.02% | -26.42% | 23.6M | 27.442M | -14.00% | -53.36% |
| Q4 2020 | -9.75 | -10.40 | 6.27% | - | 23.5M | 30.615M | -23.24% | - |
| Q3 2020 | -9.15 | -11.32 | 19.14% | - | 30M | 26.859M | 11.69% | - |
| Q2 2020 | -6.75 | -10.47 | 35.53% | - | 48.8M | 23.255M | 109.85% | - |
| Q1 2020 | -7.95 | -11.80 | 32.63% | - | 50.6M | 48.595M | 4.13% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-0.01%
Max EPS beat (4)
31.71%
Min EPS beat (4)
-43.22%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-5.38%
Max Revenue beat (4)
15.04%
Min Revenue beat (4)
-33.31%
Analysis
In the last 4 quarters, NKTR has beaten EPS estimates in 3 out of 4 releases
NKTR has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, NKTR reported -0.0% below the EPS estimates on average.
In the last 4 quarters, NKTR reported -5.4% below the revenue estimates on average.
NEKTAR THERAPEUTICS / NKTR Earnings FAQ
What is the most recent earnings date for NKTR stock?
NEKTAR THERAPEUTICS (NKTR) last reported earnings on 11/6/2025.
Did NKTR stock beat earnings estimates in the most recent quarter?
NEKTAR THERAPEUTICS (NKTR) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often NEKTAR THERAPEUTICS beats earnings estimates?
In the last 4 quarters, NEKTAR THERAPEUTICS (NKTR) has beaten EPS estimates in 3 out of 4 releases.